Researcher profile

Arzucan Özgür

Arzucan Özgür contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 19 - UnverifiedVerification L1Unclaimed author
5works
0followers
5topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

5 published item(s)

preprint2023arXiv

DebiasedDTA: A Framework for Improving the Generalizability of Drug-Target Affinity Prediction Models

Computational models that accurately predict the binding affinity of an input protein-chemical pair can accelerate drug discovery studies. These models are trained on available protein-chemical interaction datasets, which may contain dataset biases that may lead the model to learn dataset-specific patterns, instead of generalizable relationships. As a result, the prediction performance of models drops for previously unseen biomolecules, $\textit{i.e.}$ the prediction models cannot generalize to biomolecules outside of the dataset. The latest approaches that aim to improve model generalizability either have limited applicability or introduce the risk of degrading prediction performance. Here, we present DebiasedDTA, a novel drug-target affinity (DTA) prediction model training framework that addresses dataset biases to improve the generalizability of affinity prediction models. DebiasedDTA reweights the training samples to mitigate the effect of dataset biases and is applicable to most DTA prediction models. The results suggest that models trained in the DebiasedDTA framework can achieve improved generalizability in predicting the interactions of the previously unseen biomolecules, as well as performance improvements on those previously seen. Extensive experiments with different biomolecule representations, model architectures, and datasets demonstrate that DebiasedDTA can upgrade DTA prediction models irrespective of the biomolecule representation, model architecture, and training dataset. Last but not least, we release DebiasedDTA as an open-source python library to enable other researchers to debias their own predictors and/or develop their own debiasing methods. We believe that this python library will corroborate and foster research to develop more generalizable DTA prediction models.

preprint2022arXiv

A Dataset and BERT-based Models for Targeted Sentiment Analysis on Turkish Texts

Targeted Sentiment Analysis aims to extract sentiment towards a particular target from a given text. It is a field that is attracting attention due to the increasing accessibility of the Internet, which leads people to generate an enormous amount of data. Sentiment analysis, which in general requires annotated data for training, is a well-researched area for widely studied languages such as English. For low-resource languages such as Turkish, there is a lack of such annotated data. We present an annotated Turkish dataset suitable for targeted sentiment analysis. We also propose BERT-based models with different architectures to accomplish the task of targeted sentiment analysis. The results demonstrate that the proposed models outperform the traditional sentiment analysis models for the targeted sentiment analysis task.

preprint2022arXiv

Exploiting Pretrained Biochemical Language Models for Targeted Drug Design

Motivation: The development of novel compounds targeting proteins of interest is one of the most important tasks in the pharmaceutical industry. Deep generative models have been applied to targeted molecular design and have shown promising results. Recently, target-specific molecule generation has been viewed as a translation between the protein language and the chemical language. However, such a model is limited by the availability of interacting protein-ligand pairs. On the other hand, large amounts of unlabeled protein sequences and chemical compounds are available and have been used to train language models that learn useful representations. In this study, we propose exploiting pretrained biochemical language models to initialize (i.e. warm start) targeted molecule generation models. We investigate two warm start strategies: (i) a one-stage strategy where the initialized model is trained on targeted molecule generation (ii) a two-stage strategy containing a pre-finetuning on molecular generation followed by target specific training. We also compare two decoding strategies to generate compounds: beam search and sampling. Results: The results show that the warm-started models perform better than a baseline model trained from scratch. The two proposed warm-start strategies achieve similar results to each other with respect to widely used metrics from benchmarks. However, docking evaluation of the generated compounds for a number of novel proteins suggests that the one-stage strategy generalizes better than the two-stage strategy. Additionally, we observe that beam search outperforms sampling in both docking evaluation and benchmark metrics for assessing compound quality. Availability and implementation: The source code is available at https://github.com/boun-tabi/biochemical-lms-for-drug-design and the materials are archived in Zenodo at https://doi.org/10.5281/zenodo.6832145

preprint2022arXiv

Uncertainty-aware Personal Assistant for Making Personalized Privacy Decisions

Many software systems, such as online social networks enable users to share information about themselves. While the action of sharing is simple, it requires an elaborate thought process on privacy: what to share, with whom to share, and for what purposes. Thinking about these for each piece of content to be shared is tedious. Recent approaches to tackle this problem build personal assistants that can help users by learning what is private over time and recommending privacy labels such as private or public to individual content that a user considers sharing. However, privacy is inherently ambiguous and highly personal. Existing approaches to recommend privacy decisions do not address these aspects of privacy sufficiently. Ideally, a personal assistant should be able to adjust its recommendation based on a given user, considering that user's privacy understanding. Moreover, the personal assistant should be able to assess when its recommendation would be uncertain and let the user make the decision on her own. Accordingly, this paper proposes a personal assistant that uses evidential deep learning to classify content based on its privacy label. An important characteristic of the personal assistant is that it can model its uncertainty in its decisions explicitly, determine that it does not know the answer, and delegate from making a recommendation when its uncertainty is high. By factoring in the user's own understanding of privacy, such as risk factors or own labels, the personal assistant can personalize its recommendations per user. We evaluate our proposed personal assistant using a well-known data set. Our results show that our personal assistant can accurately identify uncertain cases, personalize them to its user's needs, and thus helps users preserve their privacy well.

preprint2020arXiv

Exploring Chemical Space using Natural Language Processing Methodologies for Drug Discovery

Text-based representations of chemicals and proteins can be thought of as unstructured languages codified by humans to describe domain-specific knowledge. Advances in natural language processing (NLP) methodologies in the processing of spoken languages accelerated the application of NLP to elucidate hidden knowledge in textual representations of these biochemical entities and then use it to construct models to predict molecular properties or to design novel molecules. This review outlines the impact made by these advances on drug discovery and aims to further the dialogue between medicinal chemists and computer scientists.